CDC25C and breast cancer: During the follow-up of patients, the lines corresponding to the high-expression and low-expression were found to be overlapped from 180 to 200 months (almost from 15 to 17 years) in the three plots: CDC25C in BC, RAD51 in BC and RAD51 in ER-positive BC.